266 related articles for article (PubMed ID: 29112684)
1. CXCR4/CXCR7/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma.
Werner TA; Forster CM; Dizdar L; Verde PE; Raba K; Schott M; Knoefel WT; Krieg A
Br J Cancer; 2017 Dec; 117(12):1837-1845. PubMed ID: 29112684
[TBL] [Abstract][Full Text] [Related]
2. CXCR4/CXCR7/CXCL12-Axis in Follicular Thyroid Carcinoma.
Werner TA; Forster CM; Dizdar L; Verde PE; Raba K; Schott M; Knoefel WT; Krieg A
J Cancer; 2018; 9(6):929-940. PubMed ID: 29581772
[No Abstract] [Full Text] [Related]
3. Expression and function of CXCL12/CXCR4/CXCR7 in thyroid cancer.
Zhu X; Bai Q; Lu Y; Lu Y; Zhu L; Zhou X; Wu L
Int J Oncol; 2016 Jun; 48(6):2321-9. PubMed ID: 27082011
[TBL] [Abstract][Full Text] [Related]
4. CXCR7 is not obligatory for CXCL12-CXCR4-induced epithelial-mesenchymal transition in human ovarian cancer.
Zheng N; Liu W; Chen J; Li B; Liu J; Wang J; Gao Y; Shao J; Jia L
Mol Carcinog; 2019 Jan; 58(1):144-155. PubMed ID: 30259564
[TBL] [Abstract][Full Text] [Related]
5. circPVT1 regulates medullary thyroid cancer growth and metastasis by targeting miR-455-5p to activate CXCL12/CXCR4 signaling.
Zheng X; Rui S; Wang XF; Zou XH; Gong YP; Li ZH
J Exp Clin Cancer Res; 2021 May; 40(1):157. PubMed ID: 33962657
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
7. The CXCL12-CXCR4 axis promotes migration, invasiveness, and EMT in human papillary thyroid carcinoma B-CPAP cells via NF-κB signaling.
Lin Y; Ma Q; Li L; Wang H
Biochem Cell Biol; 2018 Oct; 96(5):619-626. PubMed ID: 29316404
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS
Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
[TBL] [Abstract][Full Text] [Related]
9. High expression of CXCR4, CXCR7 and SDF-1 predicts poor survival in renal cell carcinoma.
Wang L; Chen W; Gao L; Yang Q; Liu B; Wu Z; Wang Y; Sun Y
World J Surg Oncol; 2012 Oct; 10():212. PubMed ID: 23039915
[TBL] [Abstract][Full Text] [Related]
10. CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR.
Circelli L; Sciammarella C; Guadagno E; Tafuto S; del Basso de Caro M; Botti G; Pezzullo L; Aria M; Ramundo V; Tatangelo F; Losito NS; Ieranò C; D'Alterio C; Izzo F; Ciliberto G; Colao A; Faggiano A; Scala S
Oncotarget; 2016 Apr; 7(14):18865-75. PubMed ID: 26934559
[TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic value of CXCL12/CXCR4/CXCR7 axis in clear cell renal cell carcinoma.
Potić Floranović M; Ristić Petrović A; Veličković F; Janković Veličković L
Clin Exp Nephrol; 2021 Oct; 25(10):1057-1069. PubMed ID: 34109508
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance and impact of the CXCR4-CXCR7-CXCL12 axis in primary cutaneous melanoma.
McConnell AT; Ellis R; Pathy B; Plummer R; Lovat PE; O'Boyle G
Br J Dermatol; 2016 Dec; 175(6):1210-1220. PubMed ID: 27167239
[TBL] [Abstract][Full Text] [Related]
13. The chemokine receptors CXCR4/CXCR7 and their primary heterodimeric ligands CXCL12 and CXCL12/high mobility group box 1 in pancreatic cancer growth and development: finding flow.
Shakir M; Tang D; Zeh HJ; Tang SW; Anderson CJ; Bahary N; Lotze MT
Pancreas; 2015 May; 44(4):528-34. PubMed ID: 25872129
[TBL] [Abstract][Full Text] [Related]
14. The expression of CXCR4, CXCL12 and CXCR7 in malignant pleural mesothelioma.
Li T; Li H; Wang Y; Harvard C; Tan JL; Au A; Xu Z; Jablons DM; You L
J Pathol; 2011 Mar; 223(4):519-30. PubMed ID: 21294125
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.
Wu W; Qian L; Chen X; Ding B
Int J Clin Exp Pathol; 2015; 8(10):13217-24. PubMed ID: 26722521
[TBL] [Abstract][Full Text] [Related]
16. Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph-node-positive lung cancer patients.
Katsura M; Shoji F; Okamoto T; Shimamatsu S; Hirai F; Toyokawa G; Morodomi Y; Tagawa T; Oda Y; Maehara Y
Cancer Sci; 2018 Jan; 109(1):154-165. PubMed ID: 29032612
[TBL] [Abstract][Full Text] [Related]
17. Effects of the chemokine CXCL12 and combined internalization of its receptors CXCR4 and CXCR7 in human MCF-7 breast cancer cells.
Hattermann K; Holzenburg E; Hans F; Lucius R; Held-Feindt J; Mentlein R
Cell Tissue Res; 2014 Jul; 357(1):253-66. PubMed ID: 24770893
[TBL] [Abstract][Full Text] [Related]
18. Proinflammatory CXCL12-CXCR4/CXCR7 Signaling Axis Drives Myc-Induced Prostate Cancer in Obese Mice.
Saha A; Ahn S; Blando J; Su F; Kolonin MG; DiGiovanni J
Cancer Res; 2017 Sep; 77(18):5158-5168. PubMed ID: 28687617
[TBL] [Abstract][Full Text] [Related]
19. CXCR4 Expression is Associated with Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma.
Goto M; Yoshida T; Yamamoto Y; Furukita Y; Inoue S; Fujiwara S; Kawakita N; Nishino T; Minato T; Yuasa Y; Yamai H; Takechi H; Seike J; Bando Y; Tangoku A
Ann Surg Oncol; 2017 Mar; 24(3):832-840. PubMed ID: 26577115
[TBL] [Abstract][Full Text] [Related]
20. Survivin and XIAP: two valuable biomarkers in medullary thyroid carcinoma.
Werner TA; Tamkan-Ölcek Y; Dizdar L; Riemer JC; Wolf A; Cupisti K; Verde PE; Knoefel WT; Krieg A
Br J Cancer; 2016 Feb; 114(4):427-34. PubMed ID: 26882066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]